ReviewClinical kidney journal2023

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Francesco Locatelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.